Financial Data and Key Metrics Changes - APEI's consolidated revenue for full year 2025 grew 4% to $649 million compared to 2024, despite challenges such as the mid-year sale of Graduate School USA and a registration interruption at APUS [9][23] - Adjusted EBITDA for full year 2025 reached $85.7 million, up 19% from 2024, exceeding both revised and initial guidance [9][24] - Fourth quarter revenue was $158.3 million, down 3.5% year-over-year, but exceeded guidance across all key financial metrics [19][11] Business Line Data and Key Metrics Changes - APUS revenue for Q4 2025 was $71 million, down 13.8% year-over-year due to the federal government shutdown [19] - Rasmussen's revenue for Q4 2025 increased 15.9% to $66.6 million, driven by 8.9% enrollment growth [20] - Hondros College of Nursing reported Q4 revenue of $20.7 million, up 9.2% year-over-year, with enrollment of 4,000 students, an increase of 8.1% [20] Market Data and Key Metrics Changes - APUS experienced a 41% increase in TA registrations in December 2025 compared to December 2024, indicating strong demand from military students despite the earlier registration interruption [13] - The nursing and healthcare segments showed strong performance, with Rasmussen and Hondros both achieving significant revenue growth [8][12] Company Strategy and Development Direction - APEI is focused on a four-year growth strategy introduced at the recent Investor Day, aiming to simplify and strengthen the business [8] - The company plans to combine its institutions into one system and launch new campuses in 2026, targeting markets with demonstrated demand [14][15] - APEI aims for organic revenue growth of $890 million to $925 million by 2029, with strategic investments in new campuses and potential acquisitions [31] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the long-term potential of the company, citing strong demand for nursing education and military service members [32] - The company anticipates improved profitability and cash flow due to debt refinancing and cost savings [16] - Management highlighted the resilience of military students and the ability to navigate funding disruptions without significant operational impact [27][80] Other Important Information - APEI's board authorized a $50 million share repurchase program to offset dilution from stock-based compensation [27] - The company ended 2025 with a strong balance sheet, including cash equivalents of $176.5 million and total debt of $96.4 million [25][26] Q&A Session Summary Question: CapEx cadence for new campus openings - Management expects most CapEx related to new campuses will occur in the second half of the year [35][38] Question: Expected revenue and margin for new campuses - New campuses are expected to generate about $12 million in revenue with a 35% EBITDA margin, taking 8-18 months to become cash flow positive [38] Question: Marketing strategy post-institution combination - Brands will remain present in local markets, with best practices shared across institutions to optimize marketing spend [54] Question: Impact of government shutdown on Q4 revenue - Actual impact was estimated at $12 million to $15 million short due to a strong December performance [110][117] Question: Priorities for cash use - Focus will be on organic growth, followed by opportunistic M&A, and then returning capital to shareholders [69]

Covista 2026 Investor Day Summary Company Overview - **Company Name**: Covista (NYSE: ATGE) - **Industry**: Healthcare Education - **Key Focus**: Addressing the healthcare workforce crisis by providing education and training for healthcare professionals Core Points and Arguments 1. **Healthcare Crisis**: The U.S. is facing a healthcare crisis with 76% of clinicians unable to provide desired care quality, and 395,000 unfilled healthcare roles. Covista aims to address this by educating 97,000 students annually and graduating 24,000 healthcare professionals each year [5][6][11] 2. **Rebranding and Strategy**: Covista has undergone a rebranding to position itself as a leading healthcare educator, emphasizing its unique role in the intersection of healthcare and education. The new strategy, "Purpose at Scale," aims to leverage existing assets and relationships to grow [10][11][12] 3. **Market Demand**: There is a durable demand for healthcare professionals due to workforce shortages, particularly in nursing, social work, and veterinary fields. Covista has established deep clinical relationships to meet this demand [12][20] 4. **Operational Excellence**: The company has a proven track record of operational excellence, which it plans to build upon with the new strategy. This includes focusing on marketing, enrollment, and program development [13][19] 5. **AI Integration**: Covista is investing in AI to enhance educational delivery and workforce readiness, addressing the gap between technology adoption and workforce preparedness [24][25][26] 6. **Enrollment Growth**: Covista aims to enroll over 120,000 students by fiscal 2029, with a projected revenue CAGR of 7%-10% and adjusted EPS CAGR of 10%-14% [33][34] Additional Important Insights 1. **Student Demographics**: The traditional student population is shrinking, while non-traditional students (working adults, veterans) are increasing. Covista is adapting its offerings to meet the needs of these groups [21][22] 2. **Employer Partnerships**: 97% of healthcare executives believe in the importance of partnerships with academic institutions for talent acquisition, yet only 20% are currently investing in such relationships. This presents a significant opportunity for Covista [23] 3. **Financial Performance**: Covista has exceeded its investor targets, achieving record enrollments and expanding margins while investing in competitiveness [17][18] 4. **Walden University**: Covista's Walden University has seen significant enrollment growth, particularly in graduate programs, and is positioned to lead in addressing shortages in healthcare and education [41][49][60] 5. **Innovative Programs**: Covista is launching new programs to meet market demands, including in high-demand fields like palliative care and special education [69] Conclusion Covista is strategically positioned to address the pressing healthcare workforce crisis through its educational programs and partnerships. The company's focus on operational excellence, AI integration, and innovative program offerings positions it for significant growth and impact in the healthcare education sector.

Financial Data and Key Metrics Changes - Revenue increased by 12.9% to $466.1 million, driven by enrollment growth across all segments [13] - Adjusted EBITDA rose by 19.3% to $127.8 million, with an adjusted EBITDA margin of 27.4%, expanding by 150 basis points year over year [13][14] - Adjusted net income for the quarter was $73.3 million, a 23.4% increase compared to the previous year, leading to adjusted earnings per share of $1.92, up 28% [14] Business Line Data and Key Metrics Changes - Chamberlain University reported revenue of $192.6 million, a 13.1% increase, with enrollment up 6.8% [14][15] - Walden University achieved revenue of $178.4 million, an 18.5% increase, with total student enrollment up 13.5% [16] - The Medical and Veterinary segment saw revenue of $95 million, a 3.6% increase, with enrollment up 1.2% [17] Market Data and Key Metrics Changes - Total enrollment across Adtalem institutions climbed to over 94,000 students, marking a 9.8% year-over-year increase [5] - The medical schools achieved a first-time residency attainment rate of over 95%, with significant placements in medically underserved areas [9] Company Strategy and Development Direction - The company aims to expand program capacity and invest in innovation to meet growing demand in healthcare education [10] - A new $150 million share repurchase program was announced, reflecting confidence in the strategic outlook [9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the favorable environment for career-oriented education, emphasizing high return on investment for students [28] - The company raised its 2025 revenue guidance to a range of $1.76 billion to $1.775 billion, anticipating adjusted EPS of $6.4 to $6.6 [9][19] Other Important Information - The company completed a $300 million share repurchase program, returning $763 million to shareholders since February 2022 [18] - The balance sheet remains strong, with $219 million in cash and a low adjusted EBITDA net leverage of 0.8 times [18] Q&A Session Summary Question: How do the 2026 targets stand in light of recent performance? - Management noted that the targets set at Investor Day were reasonable and they have outperformed expectations, with plans to recalibrate long-term growth targets [24][25] Question: What is the impact of recent legislative changes on student enrollment? - Management indicated no observed hesitancy among students regarding enrollment, citing strong demand for their programs [33] Question: Can you provide insight into margin degradation in the Medical and Veterinary segment? - Management explained that margin changes were due to one-time costs and investments for future growth, with confidence in long-term margin expansion [34][35] Question: What are the primary limitations on scaling up capacity? - Management identified opportunities for growth in existing programs and potential geographic expansion, with various strategies to increase capacity [50]